International Journal of Cancer Management

Published by: Kowsar

A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women

Cingeetham Vinod 1 , Akka Jyothy 1 , Malladi Vijay kumar 2 , Ramaiyer Raghu Raman 2 , Pratibha Nallari 3 and Ananthapur Venkateshwari 1 , *
Authors Information
1 Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad, India
2 MNJ Institute of Oncology and Regional Cancer Centre, University, Hyderabad, India
3 Department of Genetics, Osmania University, Hyderabad, India
Article information
  • Iranian Journal of Cancer Prevention: August 28, 2015, 8 (4); e3434
  • Published Online: August 24, 2015
  • Article Type: Research Article
  • Received: July 6, 2015
  • Accepted: July 11, 2015
  • DOI: 10.17795/ijcp-3434

To Cite: Vinod C, Jyothy A, Vijay kumar M, Raman R R, Nallari P, et al. A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women, Int J Cancer Manag. 2015 ; 8(4):e3434. doi: 10.17795/ijcp-3434.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5)-86[DOI][PubMed]
  • 2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646-74[DOI][PubMed]
  • 3. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol. 1992; 4(3): 314-20[PubMed]
  • 4. Wang R, Lu M, Zhang J, Chen S, Luo X, Qin Y, et al. Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. J Exp Clin Cancer Res. 2011; 30: 62[DOI][PubMed]
  • 5. Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res. 1999; 19(7): 697-703[DOI][PubMed]
  • 6. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24(1): 1-8[PubMed]
  • 7. Lahiri DK, Nurnberger JJ. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991; 19(19): 5444[PubMed]
  • 8. Abdolrahim-Zadeh H, Hakkakian N, Asadollahi R, Gharesifard B, Sarvari J, Kamali-Sarvestani E, et al. Interleukin-10 Promoter Polymorphisms and Breast Cancer Risk in Iranian Women. IJI. 2005; 2(3): 158-65
  • 9. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996; 77(11): 2318-24[DOI][PubMed]
  • 10. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004; 4(9): 665-76[DOI][PubMed]
  • 11. Parkin DM. International variation. Oncogene. 2004; 23(38): 6329-40[DOI][PubMed]
  • 12. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1999; 1(1): 14-7[PubMed]
  • 13. Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006; 25(43): 5898-905[DOI][PubMed]
  • 14. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics. 1997; 46(2): 120-8[PubMed]
  • 15. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol. 1995; 154(3): 1280-6[PubMed]
  • 16. Giordani L, Bruzzi P, Lasalandra C, Quaranta M, Schittulli F, Della Ragione F, et al. Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem. 2003; 49(10): 1664-7[PubMed]
  • 17. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Koppel H, et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2005; 90(2): 113-5[DOI][PubMed]
  • 18. Howell WM, Rose-Zerilli MJ. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer. 2006; 5(2): 143-9[DOI][PubMed]
  • 19. Smith KC, Bateman AC, Fussell HM, Howell WM. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet. 2004; 31(4): 167-73[DOI][PubMed]
  • 20. Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer. 2006; 6: 188[DOI][PubMed]
  • 21. Kong F, Liu J, Liu Y, Song B, Wang H, Liu W. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res. 2010; 29: 72[DOI][PubMed]
  • 22. Kang X, Kim HJ, Ramirez M, Salameh S, Ma X. The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol. 2010; 184(7): 3718-24[DOI][PubMed]
  • 23. Ursing BM, van Enckevort FH, Leunissen JA, Siezen RJ. EXProt--a database for EXPerimentally verified Protein functions. In Silico Biol. 2002; 2(1): 1-4[PubMed]
  • 24. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005; 78(5): 1043-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments